Targeted inhibition of Nodal can restore CDDP sensitivity of RCC cells, which was attributed to that Nodal can increase the transcription of ABCB1 via activation of NF-κB/p65 signals. The gene discussed is NFKB1; the disease is renal cell carcinoma.